6th Annual Pharma Marketing & Branding Excellence

Jacob Fleming Group25 - 26 January 2011, Milan, Italy.
Recently, behaviors of pharmaceutical marketing landscape, which includes health care providers, patients, and consumers are changing. Pharma companies are now favoring marketing through new media technologies like mobile-Web integration and online interactivity.

Following five successful annuals, Jacob Fleming Group invites you to the 6th Annual Pharma Marketing & Branding Excellence. Jacob Fleming Group has gathered worldwide Pharma marketing specialists who will share their knowledge with you. Hear them speak about the most powerful marketing strategies and network face-to-face.

At this conference, you will have the chance to meet true market leaders, top speakers and real experts from pharmaceutical industry. Do not miss the opportunity to gain new knowledge and join us at this event of the year.

Key speakers:

  • Senior Vice President, Global Marketing, Bayer Healthcare, Germany
  • Head of Marketing, Specialty Care Business Unit, Pfizer, Finland
  • Director Strategic Marketing, Member of the Executive Committee, Abbott, Switzerland
  • Head of Marketing Scandinavia, UCB, Norway
  • Associate Director, EMEA Marketing, Baxter, Switzerland
  • Vice President, Franchise & Global Marketing Operations, Sanofi Pasteur, France
  • Founder and managing director of Webicina.com, Author of Scienceroll.com, University of Debrecen Medical School and Health
  • Senior Marketing Director, Pfizer, UK
  • Executive Director, Global Marketing Excellence, Johnson & Johnson, UK

Key topics:

  • Case studies from top pharmaceutical companies on how to target the most interesting segments through different channels
  • Understand, how to utilize the potential of mobile marketing & achieve greater brand interactivity and immediate response metrics for your brands.
  • Real life case studies on how to expand “traditional” e-detailing beyond its current limitations
  • Working case studies on how to develop and effective social media strategy
  • Find out how to achieve branding excellence in highly competitive market place
  • Experiences of top pharmaceutical companies on how to overcome barriers for effective closed loop marketing
  • Case studies on how to built sustainable brand equity in a commoditized market
  • Real life case studies on how to successfully select the most suitable brands for e-communication

Who should attend:
Senior Vice presidents, Vice presidents, Senior Executives, Global Heads, Heads, International Directors, Senior Directors, Directors, Senior Managers, Managers of: Marketing & Sales, Marketing, Marketing excellence, CRM, e-Marketing, Branding, Communication, Business Unit Directors, Strategic Planning, Commercial operations, Strategic Marketing, Brand management, Product Directors, Key Accounts, Advertising, Market research, Business Intelligence.

For further information and registration, please visit:
http://www.jacobfleming.com/jacob-fleming-group/conferences/life-science/6th-annual-marketing-branding-excellence?partner=worldpharmanewsMB

About Jacob Fleming Group
Jacob Fleming Conferences are carefully designed to provide key strategic business information and the best networking opportunities for the participants. Our business to business conferences are highly interactive events with a limited number of delegates from specialized industry sectors. For each conference Jacob Fleming brings together selected senior level executives who become part of a premium community discussing the questions of the day and enjoying the value of a five star event.

Most Popular Now

Novo Nordisk announces plans to transform its appr…

Novo Nordisk announced plans to restructure its Research & Development (R&D) organisation to accelerate the expansion and diversification of its pipeline across serious c...

The Merck Accelerator Program 2019

The Merck Accelerator is looking for real partners so that you can work together in shaping the future. With programs in the headquarters in Germany, in China and the Sat...

World's largest Alzheimer's survey reveals most ad…

Amgen (NASDAQ:AMGN), Novartis and Banner Alzheimer's Institute (BAI), in association with Alzheimer's Disease International (ADI), announced results from the largest glob...

Imfinzi is the first immunotherapy to demonstrate …

AstraZeneca and MedImmune, its global biologics research and development arm, have presented data on overall survival (OS) in the Phase III PACIFIC trial of Imfinzi durin...

Pre-clinical success for a universal flu vaccine o…

Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Co...

Discovery could explain failed clinical trials for…

Researchers at King's College London have discovered a vicious feedback loop underlying brain degeneration in Alzheimer's disease which may explain why so many drug trial...

Global survey reveals that physicians need more in…

Results from a new global survey revealed that more than one-third (36%) of the 310 physicians surveyed do not think they have sufficient information required to make inf...

Aspirin found not to prolong healthy aging

Taking a low-dose aspirin daily does not prolong healthy living in older adults, according to findings from the ASPirin in Reducing Events in the Elderly (ASPREE) trial p...

The Lancet Respiratory Medicine publishes first Ph…

AstraZeneca today announced publication of results from the KRONOS Phase III trial which evaluated the efficacy and safety of triple combination therapy PT010 (budesonide...

In clinical trials, new antibody therapy controls …

Thanks to improvements in antiretroviral therapy, HIV is now a manageable condition. Yet even the best drugs do not entirely eliminate the virus, which latently lingers i...

FDA approves first treatment for advanced form of …

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squam...

Clinical gene discovery program solves 30 medical …

A table in a recently published paper tells the story of 30 families who have, sometimes after years of searching, finally received an answer about the condition that has...